ORVIFEBI Trademark

Trademark Overview


On Friday, September 30, 2022, a trademark application was filed for ORVIFEBI with the United States Patent and Trademark Office. The USPTO has given the ORVIFEBI trademark a serial number of 97614418. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by Merck Sharp & Dohme LLC. The ORVIFEBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders
orvifebi

General Information


Serial Number97614418
Word MarkORVIFEBI
Filing DateFriday, September 30, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Party NameMerck Sharp & Dohme LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events


Event DateEvent Description
Wednesday, June 21, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 4, 2022NEW APPLICATION ENTERED
Tuesday, October 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Wednesday, June 21, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, June 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 21, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, June 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 27, 2024SOU EXTENSION 1 FILED
Tuesday, February 27, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 2 FILED
Wednesday, August 21, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED